432 related articles for article (PubMed ID: 26769827)
1. New insights into tryptophan and its metabolites in the regulation of bone metabolism.
Michalowska M; Znorko B; Kaminski T; Oksztulska-Kolanek E; Pawlak D
J Physiol Pharmacol; 2015 Dec; 66(6):779-91. PubMed ID: 26769827
[TBL] [Abstract][Full Text] [Related]
2. The multiple faces of tryptophan in bone biology.
Al Saedi A; Sharma S; Summers MA; Nurgali K; Duque G
Exp Gerontol; 2020 Jan; 129():110778. PubMed ID: 31705966
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
Nayak BN; Buttar HS
J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of toxic products degradation of kynurenine in hemodialyzed patients.
Pawlak D; Pawlak K; Malyszko J; Mysliwiec M; Buczko W
Int Urol Nephrol; 2001; 33(2):399-404. PubMed ID: 12092667
[TBL] [Abstract][Full Text] [Related]
6. An expanding range of targets for kynurenine metabolites of tryptophan.
Stone TW; Stoy N; Darlington LG
Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
[TBL] [Abstract][Full Text] [Related]
7. Kynurenine pathway metabolism in patients with osteoporosis after 2 years of drug treatment.
Forrest CM; Mackay GM; Oxford L; Stoy N; Stone TW; Darlington LG
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1078-87. PubMed ID: 17042918
[TBL] [Abstract][Full Text] [Related]
8. The kynurenine pathway of tryptophan degradation is activated during osteoblastogenesis.
Vidal C; Li W; Santner-Nanan B; Lim CK; Guillemin GJ; Ball HJ; Hunt NH; Nanan R; Duque G
Stem Cells; 2015 Jan; 33(1):111-21. PubMed ID: 25186311
[TBL] [Abstract][Full Text] [Related]
9. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
[TBL] [Abstract][Full Text] [Related]
10. Relationships between methoxyindole and kynurenine pathway metabolites in plasma and urine in children suffering from febrile and epileptic seizures.
Muñóz-Hoyos A; Molina-Carballo A; Rodríguez-Cabezas T; Uberos-Fernández J; Ruiz-Cosano C; Acuña-Castroviejo D
Clin Endocrinol (Oxf); 1997 Dec; 47(6):667-77. PubMed ID: 9497873
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan metabolites and brain disorders.
Stone TW; Mackay GM; Forrest CM; Clark CJ; Darlington LG
Clin Chem Lab Med; 2003 Jul; 41(7):852-9. PubMed ID: 12940508
[TBL] [Abstract][Full Text] [Related]
12. [Kynurenines in pathogenesis of endogenous psychiatric disorders].
Shilov IuE; Bezrukov MV
Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637
[TBL] [Abstract][Full Text] [Related]
13. Changes in kynurenine pathway metabolism in the brain, liver and kidney of aged female Wistar rats.
Braidy N; Guillemin GJ; Mansour H; Chan-Ling T; Grant R
FEBS J; 2011 Nov; 278(22):4425-34. PubMed ID: 22032336
[TBL] [Abstract][Full Text] [Related]
14. Central kynurenine pathway shift with age in women.
de Bie J; Guest J; Guillemin GJ; Grant R
J Neurochem; 2016 Mar; 136(5):995-1003. PubMed ID: 26670548
[TBL] [Abstract][Full Text] [Related]
15. The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation.
Maes M; Mihaylova I; Ruyter MD; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):826-31. PubMed ID: 18063923
[TBL] [Abstract][Full Text] [Related]
16. The analgesic effects of tryptophan and its metabolites in the rat.
Heyliger SO; Goodman CB; Ngong JM; Soliman KF
Pharmacol Res; 1998 Oct; 38(4):243-50. PubMed ID: 9774487
[TBL] [Abstract][Full Text] [Related]
17. Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: A case-control study.
Colle R; Masson P; Verstuyft C; Fève B; Werner E; Boursier-Neyret C; Walther B; David DJ; Boniface B; Falissard B; Chanson P; Corruble E; Becquemont L
Psychiatry Clin Neurosci; 2020 Feb; 74(2):112-117. PubMed ID: 31599111
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis kynurenic and quinolinic acids: The main players of the kynurenine pathway and opponents in inflammatory disease.
Badawy AA
Med Hypotheses; 2018 Sep; 118():129-138. PubMed ID: 30037600
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401.
Mor A; Pawlak K; Kalaska B; Domaniewski T; Sieklucka B; Zieminska M; Cylwik B; Pawlak D
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825192
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan catabolism in Pseudomonas aeruginosa and potential for inter-kingdom relationship.
Bortolotti P; Hennart B; Thieffry C; Jausions G; Faure E; Grandjean T; Thepaut M; Dessein R; Allorge D; Guery BP; Faure K; Kipnis E; Toussaint B; Le Gouellec A
BMC Microbiol; 2016 Jul; 16(1):137. PubMed ID: 27392067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
